Schreiner MediPharm this week launched its late-stage customization capabilities for its RFID-Labels series. The new offering allows the company’s smart labels to be supplied quickly with order-specific programming for integrated RFID chips. Schreiner MediPharm’s RFID functional labels give pharmaceutical companies the flexibility and agility to provide the best possible security of supply and quality assurance…
Ferring Pharmaceuticals, SK Pharmteco enter commercial gene therapy manufacturing deal
Ferring Pharmaceuticals and SK pharmteco today announced an agreement to scale up commercial manufacturing capacity for Ferring’s drug substance intravesical non-replicating gene therapy, Adstiladrin. The deal will help ensure the long-term future supply of gene therapy. Following the technology transfer, SK pharmteco will be qualified as another source for manufacturing, testing and release of the…
TriLink BioTechnologies opens new mRNA manufacturing facility
TriLink BioTechnologies today announced it opened its new cGMP mRNA manufacturing facility. The new 32,000 sq. ft. facility, based in San Diego, is specifically designed for mRNA manufacturing. Using the company’s mRNA manufacturing capabilities, it will support late-phase drug developers from Phase 2 to commercialization. TriLink said the opening is expected to help advance the…
KBI Biopharma names new chief business officer
KBI Biopharma this week announced it appointed Jean-Baptiste Agnus as chief business officer, effective immediately. Angus has more than two decades of experience across various sectors of the biopharmaceutical industry with expertise in commercial development in biologics, small molecule APIs, antibody-drug conjugates, and cell and gene therapies. As chief business officer, Angus will lead KBI’s…
Sen-Jam Pharma, KVK-Tech partnering for manufacturing and formulation for anti-inflammatory injectables
Sen-Jam Pharmaceutical this week announced it is partnering with specialty pharmaceutical manufacturer KVK-Tech for formulation and chemistry, manufacturing and controls for anti-inflammatory injectables. The partnership is the third development, manufacturing, distribution and license agreement the pair have signed. The new partnership will further advance Sen-Jam’s first injectable anti-inflammatory therapeutic, SJP-100. Sen-Jam is developing an immunomodulator…
Fujifilm invests $1.2 billion in North Carolina biopharmaceutical manufacturing facility
Fujifilm Diosynth Biotechnologies is investing $1.2 billion to expand its biopharmaceutical manufacturing facility in Holly Springs, N.C. Fujifilm initially invested $2 billion in the Holly Springs operation in 2021. The company said the investment made it one of North America’s largest end-to-end biopharmaceutical manufacturing facilities. The new expansion will create 680 new jobs in the…
Novo Nordisk and Ginkgo Bioworks extend manufacturing, R&D partnership
Ginkgo Bioworks today announced it expanded its strategic partnership with Novo Nordisk to manufacture medicines for chronic diseases. Under the framework agreement, the partnership is slated to run over five years. Ginkgo Bioworks develops a platform for cell programming and biosecurity, while Novo Nordisk develops a series of medications for chronic conditions, including its Wegovy…
Pharmaceutical manufacturer Grindeks opens 28 global subsidiaries
Latvian pharmaceutical manufacturing company Grindeks recently announced it opened 28 new subsidiaries in Europe to develop new products. Grindeks provides a full product lifecycle, including research, development, pharmacovigilance, manufacturing, and sales of original products, generic drugs and active pharmaceutical ingredients. It specializes in cardiology, central nervous system, oncology, diabetes and dermatology. With the new expanded…
ProMed Pharma acquires SpineThera’s manufacturing facilities, has option to license IP
ProMed Pharma this week announced it acquired SpineThera’s manufacturing capabilities with the option to license intellectual property. Under the terms of the acquisition, ProMed Pharma has the option to license SpineThera’s microsphere intellectual property, which it could sublicense to ProMed Pharma’s customers. The Plymouth, Minnesota-based contract manufacturer will also add biodegradable microparticle development and manufacturing…
Astellas breaks ground on €330M manufacturing facility in Ireland
Astellas Pharma announced that it broke ground on a construction site for a state-of-the-art production facility in Ireland. The company invested €330 million in the facility situated at Kerry Technology Park in Tralee, Co. Kerry. Astellas designed the facility with sustainability front of mind. It expects the plant to accelerate the expansion of its in-house…